SOST and coronary artery disorder: In confounder‐adjusted analyses in LURIC, sclerostin was positively related to CAD severity at study entry, as reflected by Friesinger score and coronary artery stenosis, and with cardiac mortality after follow‐up for a mean of 9.9 years.